|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
CA2935960C
(en)
|
2014-01-08 |
2023-01-10 |
Bart Lipkens |
Acoustophoresis device with dual acoustophoretic chamber
|
|
US10441654B2
(en)
|
2014-01-24 |
2019-10-15 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
SMC combination therapy for the treatment of cancer
|
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
KR102576042B1
(ko)
|
2016-10-11 |
2023-09-07 |
아게누스 인코포레이티드 |
항-lag-3 항체 및 이의 사용 방법
|
|
KR20240024328A
(ko)
|
2016-11-22 |
2024-02-23 |
알로플렉스 바이오테라퓨틱스 |
동종이형 종양 세포 백신
|
|
US11185586B2
(en)
|
2016-11-22 |
2021-11-30 |
Alloplex Biotherapeutics, Inc. |
Allogeneic tumor cell vaccine
|
|
WO2018152572A1
(en)
*
|
2017-02-21 |
2018-08-30 |
The University Of Adelaide |
T cells expressing chemokine receptors for treating cancer
|
|
JP2020516654A
(ja)
|
2017-04-13 |
2020-06-11 |
センティ バイオサイエンシズ インコーポレイテッド |
組み合わせがん免疫療法
|
|
US20210095029A1
(en)
*
|
2017-04-19 |
2021-04-01 |
University Of Southern California |
Compositions and methods for treating cancer
|
|
WO2019000223A1
(en)
|
2017-06-27 |
2019-01-03 |
Nanjing Legend Biotech Co., Ltd. |
ENABLERS OF IMMUNE EFFECTOR CELLS OF CHIMERIC ANTIBODIES AND METHODS OF USE THEREOF
|
|
US20210130775A1
(en)
*
|
2017-08-02 |
2021-05-06 |
Autolus Limited |
Cells expressing a chimeric antigen receptor or engineered tcr and comprising a nucleotide sequence which is selectively expressed
|
|
GB201713078D0
(en)
*
|
2017-08-15 |
2017-09-27 |
Adaptimmune Ltd |
T Cell Modification
|
|
US12385061B2
(en)
|
2017-09-08 |
2025-08-12 |
Poseida Therapeutics, Inc. |
Compositions and methods for chimeric ligand receptor (CLR)-mediated conditional gene expression
|
|
CA3079076A1
(en)
*
|
2017-10-18 |
2019-04-25 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Methods and compounds for improved immune cell therapy
|
|
SG11202003907WA
(en)
|
2017-12-14 |
2020-05-28 |
Flodesign Sonics Inc |
Acoustic transducer drive and controller
|
|
GB201721802D0
(en)
*
|
2017-12-22 |
2018-02-07 |
Almac Discovery Ltd |
Ror1-specific antigen binding molecules
|
|
AU2019221324A1
(en)
*
|
2018-02-15 |
2020-09-03 |
The National Institute for Biotechnology in the Negev Ltd. |
Tumor environment-specific expression of chimeric antigen receptors
|
|
JP7154634B2
(ja)
*
|
2018-03-13 |
2022-10-18 |
国立大学法人大阪大学 |
腫瘍免疫賦活剤
|
|
WO2019199689A1
(en)
*
|
2018-04-09 |
2019-10-17 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions comprising a viral vector for expression of a transgene and an effector
|
|
CN110615842B
(zh)
*
|
2018-06-20 |
2023-05-09 |
上海隆耀生物科技有限公司 |
一种包含共刺激受体的嵌合抗原受体及应用
|
|
CN108913718A
(zh)
*
|
2018-07-20 |
2018-11-30 |
苏州茂行生物科技有限公司 |
一种靶向EGFR vⅢ的CAR-T细胞的制备方法及应用
|
|
CN108949825A
(zh)
*
|
2018-07-30 |
2018-12-07 |
苏州茂行生物科技有限公司 |
一种靶向her2的car-t细胞的制备方法及应用
|
|
US11866494B2
(en)
*
|
2018-08-31 |
2024-01-09 |
Innovative Cellular Therapeutics Holdings, Ltd. |
CAR T therapy through uses of co-stimulation
|
|
JP7558151B2
(ja)
*
|
2018-09-05 |
2024-09-30 |
アダプティミューン・リミテッド |
Ｔ細胞改変
|
|
WO2020052542A1
(en)
|
2018-09-10 |
2020-03-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies against cll1 and constructs thereof
|
|
US11419898B2
(en)
|
2018-10-17 |
2022-08-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
TW202035685A
(zh)
|
2018-10-17 |
2020-10-01 |
美商聖堤生物科技股份有限公司 |
組合癌症免疫療法
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
EP3873540A4
(en)
|
2018-10-31 |
2022-07-27 |
Mayo Foundation for Medical Education and Research |
METHODS AND MATERIALS FOR THE TREATMENT OF CANCER
|
|
CA3116412A1
(en)
|
2018-10-31 |
2020-05-07 |
Humanigen, Inc. |
Materials and methods for treating cancer
|
|
EP3876977A1
(en)
|
2018-11-06 |
2021-09-15 |
The Regents Of The University Of California |
Chimeric antigen receptors for phagocytosis
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
US20210369776A1
(en)
*
|
2018-12-06 |
2021-12-02 |
Guangdong Tcrcure Biopharma Technology Co., Ltd. |
Combinational tcr-t cell therapy targeting tumor antigens, tgf-beta, and immune checkpoints
|
|
AU2020218546A1
(en)
*
|
2019-02-08 |
2021-09-09 |
Dna Twopointo Inc. |
Transposon-based modifications of immune cells
|
|
US12419913B2
(en)
|
2019-02-08 |
2025-09-23 |
Dna Twopointo, Inc. |
Modification of CAR-T cells
|
|
US20220088075A1
(en)
*
|
2019-02-22 |
2022-03-24 |
The Trustees Of The University Of Pennsylvania |
Combination therapies of egfrviii chimeric antigen receptors and pd-1 inhibitors
|
|
WO2020181221A1
(en)
*
|
2019-03-07 |
2020-09-10 |
Children's Medical Center Corporation |
Targeted delivery of immune-modulating vhh and vhh-fusion protein
|
|
WO2020219504A1
(en)
*
|
2019-04-23 |
2020-10-29 |
The Regents Of The University Of California |
Modulating survival of therapeutic cells and methods, cells and nucleic acids related thereto
|
|
US11013764B2
(en)
|
2019-04-30 |
2021-05-25 |
Myeloid Therapeutics, Inc. |
Engineered phagocytic receptor compositions and methods of use thereof
|
|
WO2021016598A1
(en)
*
|
2019-07-25 |
2021-01-28 |
Immunowake Inc. |
Methods of measuring cell-mediated killing by effectors
|
|
CA3149395A1
(en)
*
|
2019-08-01 |
2021-02-04 |
Memorial Sloan-Kettering Cancer Center |
Cells for improved immunotherapy and uses thereof
|
|
WO2021041920A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
KR20220097875A
(ko)
|
2019-09-03 |
2022-07-08 |
마이얼로이드 테라퓨틱스, 인크. |
게놈 통합을 위한 방법 및 조성물
|
|
JP7752424B2
(ja)
*
|
2019-10-22 |
2025-10-10 |
アロプレックス バイオセラピューティクス |
シリアルキラーｔ細胞集団のインビトロ活性化及び拡大、ならびに腫瘍細胞殺傷細胞を有するがん患者の受動免疫化のための組成物及び方法
|
|
CN115297873A
(zh)
*
|
2019-11-08 |
2022-11-04 |
梅约医学教育与研究基金会 |
利用工程化改造的间充质干细胞治疗炎症和退行性疾病的方法和物质
|
|
CN112941028A
(zh)
*
|
2019-12-09 |
2021-06-11 |
上海细胞治疗集团有限公司 |
纳米抗体基因修饰的间充质干细胞及其制备方法与应用
|
|
US10980836B1
(en)
|
2019-12-11 |
2021-04-20 |
Myeloid Therapeutics, Inc. |
Therapeutic cell compositions and methods of manufacturing and use thereof
|
|
AU2021208433A1
(en)
*
|
2020-01-14 |
2022-07-14 |
Adaptimmune Limited |
Method of treatment of cancer or tumour
|
|
MX2022010549A
(es)
|
2020-02-26 |
2022-11-16 |
Biograph 55 Inc |
Moleculas de union compuestas que se dirigen a celulas b inmunodepresoras.
|
|
WO2021197430A1
(en)
*
|
2020-04-01 |
2021-10-07 |
Nanjing Legend Biotech Co., Ltd. |
Compositions and methods for reducing graft rejection in allogeneic cell therapy
|
|
WO2022005994A1
(en)
*
|
2020-06-29 |
2022-01-06 |
Memorial Sloan Kettering Cancer Center |
C825 expressing immune cells and diagnostic uses thereof
|
|
WO2022012680A1
(en)
|
2020-07-16 |
2022-01-20 |
Nanjing Legend Biotech Co., Ltd. |
Cd20 binding molecules and uses thereof
|
|
AU2021334950A1
(en)
*
|
2020-08-24 |
2023-03-02 |
Charité - Universitätsmedizin Berlin |
Chimeric antigen receptor (CAR)-expressing cells recognizing CEA
|
|
AU2021368557A1
(en)
*
|
2020-10-27 |
2023-06-08 |
Adoc Ssf, Llc |
Compositions and methods for the treatment of cancer using next generation engineered t cell therapy
|
|
JP2023549140A
(ja)
|
2020-11-04 |
2023-11-22 |
マイエロイド・セラピューティクス，インコーポレーテッド |
操作されたキメラ融合タンパク質組成物およびその使用方法
|
|
US12234473B2
(en)
|
2020-12-31 |
2025-02-25 |
Immatics US, Inc. |
CD8 polypeptides, compositions, and methods of using thereof
|
|
KR20240013094A
(ko)
|
2021-03-17 |
2024-01-30 |
마이얼로이드 테라퓨틱스, 인크. |
조작된 키메라 융합 단백질 조성물 및 그의 사용 방법
|
|
BR112023023642A2
(pt)
|
2021-05-11 |
2024-01-30 |
Myeloid Therapeutics Inc |
Métodos e composições para integração genômica
|
|
US20240285760A1
(en)
*
|
2021-06-24 |
2024-08-29 |
Georgia Tech Research Corporation |
Methods and compositions for remote control of t cell therapies by thermal targeting
|
|
CN113789299B
(zh)
*
|
2021-10-18 |
2023-03-24 |
新鲁细胞生物科技(海南)有限公司 |
一种脐血nk细胞的体外增殖培养基、体外培养试剂盒和体外培养方法
|
|
TW202426477A
(zh)
*
|
2022-10-07 |
2024-07-01 |
美商聖堤生物科技股份有限公司 |
經武裝之嵌合受體及其使用方法
|
|
WO2024107410A1
(en)
*
|
2022-11-14 |
2024-05-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cd39 selection for cytotoxicity of genetically engineered t regulatory cells
|
|
CN121263449A
(zh)
|
2023-03-21 |
2026-01-02 |
拜格拉夫55公司 |
Cd19/cd38多特异性抗体
|
|
FI131854B1
(en)
|
2023-05-29 |
2026-01-12 |
Onni Biotechnologies Oy |
Modified natural killer cells with enhanced cytotoxic activity and greater survival
|
|
WO2025081190A1
(en)
*
|
2023-10-12 |
2025-04-17 |
Georgia Tech Research Corporation |
Image guided car t cell therapy to treat brain tumors
|